English
|
Spanish
Login
Register
For the latest
e
cancer COVID-19 resources, click on this link
Home
News
Journal
Video
e
learning
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
News
e
cancer sources relevant oncology news from key institutes, journals, governments, NGOs and charities, along with commissioned pieces from our dedicated news team.
Latest news
Category
All
Disease Areas
Patient Care
Policy
Prevention & screening
Treatments
Sub-category
All
Conference
All
ESMO 2020
EHA 2020
ASCO 2020
AACR 2020
ecancer COVID-19 Resources
COVID-19 Recursos
SABCS 2019
ASH 2019
ESMO 2019
EHA 2019
ASCO 2019
European Lung Cancer Congress 2019
AACR 2019
2019 Genitourinary Cancers Symposium
SABCS 2018
ASH 2018
ESMO 2018
EHA 2018
2018 ASCO Annual Meeting
CRUK Brain Tumour Conference
AACR 2018
2018 Genitourinary Cancers Symposium
ASH 2017
SABCS 2017
EAPM 2017
ASTRO
Year
All
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Keyword
COVID-19 and cancer: Useful resources
COVID-19 and cancer intelligence hub
ESMO 2020: Immunotherapy is beneficial in gastric and oesophageal cancers
ESMO 2020: Amivantamab with lazertinib in patients with EGFR-mutated non-small cell lung cancer
ESMO 2020: No benefit for post-operative radiotherapy in non-small-cell lung cancer
ESMO 2020: PARP inhibitor olaparib for the targeted treatment of metastatic prostate cancer
ESMO 2020: First new drug in years reduces recurrence in high-risk hormone receptor positive early b...
ESMO 2020: First-time data revealed from two studies evaluating pembrolizumab plus lenvatinib in sev...
ESMO 2020: Sacituzumab govitecan-hziy extends survival in phase 3 ASCENT study of metastatic triple-...
ESMO 2020: KRAS inhibitor sotorasib appears safe, achieves durable clinical benefit in early trial
1
2
3
4
5
...
1557
Tweets by @ecancer
More from
e
cancer
